TPH1 and Schwartz-Jampel syndrome: Furthermore, in vivo, the administration of cytokines known to activate Tph cells (IL-12, TGF-β1, and IFN-α) further reduced saliva production and worsened SjS-like symptoms in CD8TΔhPBMC mice (Figure 6, A and B).